Q&A: How Monogram’s CEO plans to disrupt robotic joint replacement surgery

By /

The robot developer’s CEO, Benjamin Sexson, tells MedTech Dive why he believes the orthopedics market needs a fresh approach to joint reconstruction.

Scroll to Top